Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01558570 · ClinicalTrials.gov registry record
Intracellular Tight Junction Permeability in Schizophrenia: Focus on Zonulin
A clinical trial, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- 100
- Enrollment target
NCT01558570 is a clinical trial that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 100 participants.
The verdict
NCT01558570 has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The purpose of this protocol is to collect serum zonulin levels in people with schizophrenia. This one time visit will collect zonulin levels, antibodies to gliadin (tissue transglutaminase and antigliadin antibodies) and other information that may relate to increased intracellular tight junction permeability as it related to the immune and stress system and the immune association with kynurenic acid pathway 50. Data will be collected for use in future grant applications and published reports.
Interventions
- PROCEDURE Blood Draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2011-07 |
| Est. Completion | 2012-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01558570
The ClinicalTrials.gov registry entry for NCT01558570 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood Draw is the first listed.
NCT01558570 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01558570 about?
NCT01558570 is a clinical study titled "Intracellular Tight Junction Permeability in Schizophrenia: Focus on Zonulin". The purpose of this protocol is to collect serum zonulin levels in people with schizophrenia. This one time visit will collect zonulin levels, antibodies to gliadin (tissue transglutaminase and antigliadin antibodies) and other information that may relate to increased intracellular tight junction pe...
What is the current status of trial NCT01558570?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2011-07. Estimated completion is 2012-02.
What interventions are being tested in trial NCT01558570?
The interventions under investigation include: Blood Draw (PROCEDURE).
Who is sponsoring clinical trial NCT01558570?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.